Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity
Authors:
- Toshio KinoshitaTKToshio Kinoshita
- Hitomi YuzawaHYHitomi Yuzawa
- Kazuhiko NatoriKNKazuhiko Natori
- Ryo WadaRWRyo Wada
- Shintaro YaoSYShintaro Yao
- Kensuke YanoKYKensuke Yano
- Katsuya AkitsuKAKatsuya Akitsu
- Hideki KoikeHKHideki Koike
- Masaya ShinoharaMSMasaya Shinohara
- Tadashi FujinoTFTadashi Fujino
- Hideaki ShimadaHSHideaki Shimada
- Takanori IkedaTITakanori Ikeda
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Journal of Cardiology
- Vol. 77 (4) , 388-394
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Dexrazoxane protects the heart from acute doxorubicin‐induced QT prolongation: a key role forIKsBritish Journal of Pharmacology, 2010
- Anthracycline-Induced CardiomyopathyJACC, 2010
- Protective Effects of Carvedilol Against Anthracycline-Induced CardiomyopathyJACC, 2006
- Anthracycline cardiotoxicityExpert Opinion on Drug Safety, 2006
- Doxorubicin-induced second degree and complete atrioventricular blockEP Europace, 2005
- QT dispersion and late potentials during doxorubicin therapy for non‐Hodgkin’s lymphomaJournal of Internal Medicine, 1999
- Electrocardiographic changes and arrhythmias after cancer therapy in children and young adultsThe American Journal of Cardiology, 1992
- Doxorubicin Cardiotoxicity in the RatJournal of Cardiovascular Pharmacology, 1984
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976